crc press - E-Lib FK UWKS

The Tat-Derived Cell-Penetrating Peptide 21
52. Mitchell, D.J. et al., Polyarginine enters cells more efficiently than other polycationic
homopolymers, J. Pept. Res., 56, 318–325, 2000.
53. Abu-Amer, Y. et al., TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha
arrest osteoclastogenesis, J. Biol. Chem., 276, 30499–30503, 2001.
54. Rothbard, J.B. et al., Conjugation of arginine oligomers to cyclosporin A facilitates
topical delivery and inhibition of inflammation, Nat. Med., 6, 1253–1257, 2000.
55. Kurzchalia, T.V. and Parton, R.G., Membrane microdomains and caveolae, Curr.
Opin. Cell. Biol., 11, 424–431, 1999.
56. Gumbleton, M., Abulrob, A.G., and Campbell, L., Caveolae: an alternative membrane
transport compartment, Pharm. Res., 17, 1035–1048, 2000.
57. Anderson, R.G. et al., Potocytosis: sequestration and transport of small molecules by
caveolae, Science, 255, 410–411, 1992.
58. Dostmann, W.R. et al., Highly specific, membrane-permeant peptide blockers of
cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation, Proc.
Natl. Acad. Sci. USA, 97, 14772–14777, 2000.
59. Bonny, C. et al., Cell-permeable peptide inhibitors of JNK: novel blockers of betacell
death, Diabetes, 50, 77–82, 2001.
60. Li, H. et al., Cholesterol binding at the cholesterol recognition/interaction amino acid
consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of
steroidogenesis by an HIV TAT-CRAC peptide, Proc. Natl. Acad. Sci. USA, 98,
1267–1272, 2001.
61. Stein, S. et al., A disulfide conjugate between anti-tetanus antibodies and HIV (37-72)
Tat neutralizes tetanus toxin inside chromaffin cells, FEBS Lett., 458, 383–386, 1999.
62. Caron, N.J. et al., Intracellular delivery of a Tat-eGFP fusion protein into muscle
cells, Mol. Ther., 3, 310–318, 2001.
63. Prochiantz, A., Getting hydrophilic compounds into cells: lessons from homeopeptides,
Curr. Opin. Neurobiol., 6, 629–634, 1996.
64. Falnes, P.O., Wesche, J., and Olsnes, S., Ability of the Tat basic domain and VP22
to mediate cell binding, but not membrane translocation of the diphtheria toxin
A-fragment, Biochemistry, 40, 4349–4358, 2001.
65. Taylor, C.T. et al., Phosphorylation-dependent targeting of cAMP response element
binding protein to the ubiquitin/proteasome pathway in hypoxia, Proc. Natl. Acad.
Sci. USA, 97, 12091–12096, 2000.